Bill Search

  • Introduced
    Sep 14, 2021
  • Passed House
  • Passed Senate
  • Signed into Law
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
HR 5260
United States House Bill
To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.
Last Action
House • Sep 14, 2021: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Do you support this bill?
Yay Nay

Official Summary/Bill Text

Comments on Bill

Tweets

Whip Lists

Sponsors:
Votes
Actions
  • Sep 14, 2021 | House
    • Introduced in House
    • Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    • Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    • Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill Texts
Documents